Your browser doesn't support javascript.
loading
A GIP/xenin hybrid in combination with exendin-4 improves metabolic status in db/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice.
Craig, S L; Perry, R A; Vyavahare, S S; Ng, M T; Gault, V A; Flatt, P R; Irwin, N.
Affiliation
  • Craig SL; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, UK.
  • Perry RA; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, UK.
  • Vyavahare SS; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, UK.
  • Ng MT; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, UK.
  • Gault VA; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, UK.
  • Flatt PR; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, UK.
  • Irwin N; SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, Northern Ireland, UK. Electronic address: n.irwin@ulster.ac.uk.
Biochem Pharmacol ; 171: 113723, 2020 01.
Article in En | MEDLINE | ID: mdl-31756326

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurotensin / Gastric Inhibitory Polypeptide / Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 2 / Energy Metabolism / Exenatide Type of study: Etiology_studies Limits: Animals Language: En Journal: Biochem Pharmacol Year: 2020 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurotensin / Gastric Inhibitory Polypeptide / Diabetes Mellitus, Experimental / Diabetes Mellitus, Type 2 / Energy Metabolism / Exenatide Type of study: Etiology_studies Limits: Animals Language: En Journal: Biochem Pharmacol Year: 2020 Document type: Article Country of publication: United kingdom